TABLE 1.
Demographics and clinical characteristics of patients with blaVIM-1-positive Enterobacter infection versus patients with blaVIM-1-negative Enterobacter infection
| Parameter | Value |
P valuea | |
|---|---|---|---|
| blaVIM-1-positive infection (n = 7) | blaVIM-1-negative infection (n = 22) | ||
| Age (yr) (median [range]) | 68 (49-79) | 61.5 (20-81) | 1.0 |
| Male sex (no. [%]) | 5 (71.4) | 15 (68) | 0.4 |
| No. (%) of patients with underlying disease | |||
| Cirrhosis | 3 (42.8) | 1 (4.5) | 0.03 |
| Neoplasm | 3 (42.8) | 8 (36.3) | 1.0 |
| Chronic obstructive pulmonary disease | 0 | 2 (9) | 1.0 |
| Diabetes | 2 (28.5) | 5 (22.7) | 1.0 |
| Hemodialysis | 1 (14.2) | 0 | 0.2 |
| Heart failure | 0 | 7 (31.8) | 0.1 |
| Trauma | 1 (14.2) | 2 (9) | 1.0 |
| Dementia | 0 | 2 (9) | 1.0 |
| No. (%) of patients with history of recent infection (3 mo) | 6 (85.7) | 9 (41) | 0.08 |
| No. (%) of patients with prior hospitalization (3 mo) | 7 (100) | 8 (36.3) | 0.006 |
| No. (%) of patients with prior antibiotic therapy (30 days) | 7 (100) | 15 (68) | 0.1 |
| SOFA score (mean) | 4.4 | 3.9 | 0.6 |
| No. (%) of patients with severe sepsis | 5 (71.4) | 9 (41) | 0.2 |
a
Values in bold indicate statistical significance.